IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma
Clinical trial NCT04109456 · COMPLETED
Trial details
- NCT number
- NCT04109456
- Sponsor
- InxMed (Shanghai) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-16
- Primary completion
- 2024-12-20
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.